Why is Krebs Biochem falling/rising?

As of 12-Nov, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at Rs 66.89, which reflects a decrease of Rs 3.05 or 4.36%. The stock has underperformed significantly today, with a performance that is 5.34% lower than its sector. It opened with a loss of 2.77% and reached an intraday low of Rs 66.89. Additionally, the stock is trading below all key moving averages, indicating a bearish trend. Over the past week, the stock has fallen by 5.51%, and its year-to-date performance shows a substantial decline of 27.69%. Notably, investor participation has dropped sharply, with delivery volume plummeting by 92.31% compared to the five-day average, suggesting a lack of confidence among investors.
In the broader market context, Krebs Biochem's performance contrasts sharply with the Sensex, which has gained 1.21% over the past week and 8.10% year-to-date. This divergence indicates that while the overall market is experiencing positive momentum, Krebs Biochem is struggling significantly. The stock's performance over the last month and year also reveals a downward trend, with declines of 7.29% and 23.11%, respectively, further highlighting its underperformance relative to the benchmark. The stock's proximity to its 52-week low, being only 4.99% away, adds to the negative sentiment surrounding it.